Results 311 to 320 of about 377,080 (350)
Some of the next articles are maybe not open access.

Positron Emission Tomography

Physica Scripta, 1987
An overview is presented of the basic principles, the physics constrains and the practical limitations of Positron Emission Tomography. The most recent developments in PET instrumentation and the actual trends are discussed. Finally, some clinical applications are described.
openaire   +3 more sources

Positron emission tomography in neuropsychology

Neuropsychologia, 1986
By positron emission tomography (PET) of 18F-2-fluoro-2-deoxy-D-glucose (FDG) local cerebral metabolic rate for glucose (LCMRGl) can be measured in man. Normal values in cerebral cortex and basal ganglia range from 35 to 50 mumol/100 g/min, the values in gray matter structures of the posterior fossa were 25-30 mumol/100 g/min, the lowest LCMRGl was ...
W.-D. Heiss   +4 more
openaire   +3 more sources

18F-Fluoride Positron Emission Tomography and Positron Emission Tomography/Computed Tomography

Seminars in Nuclear Medicine, 2007
(18)F-Fluoride is a positron-emitting bone-seeking agent, the uptake of which reflects blood flow and remodeling of bone. Assessment of (18)F-fluoride kinetics using quantitative positron emission tomography (PET) methods allows the regional characterization of lesions of metabolic bone diseases and the monitoring of their response to therapy.
Ur Metser   +3 more
openaire   +3 more sources

Positron Emission Tomography and Profiling

ChemInform, 2005
AbstractFor Abstract see ChemInform Abstract in Full Text.
van Ra Rutger Santen   +2 more
openaire   +3 more sources

Positron emission tomography

Brain Topography, 1992
Positron emission tomography (PET) allows for the absolute measurement of regional tissue physiological, biochemical and pharmacological processes. This ability is a consequence of the nature of positron emission and the type of tracers which can be labelled with positron emitting radionuclides. The spatial resolution of state of the art scanners is in
openaire   +3 more sources

Positron emission tomography in the lung

Journal of Thoracic Imaging, 1985
Positron emission tomography using the ECAT II scanner to image and measure regional lung function is outlined. The combined use of transmission and emission imaging provides quantitative information about regional lung structure (density, extravascular density, and vascular volume) and function (ventilation, perfusion, ventilation-perfusion ratios ...
L. H. Brudin   +3 more
openaire   +3 more sources

Positron emission tomography (PET)

Journal of Medical Systems, 1982
Among emerging medical diagnostic imaging modalities, positron emission tomography, often abbreviated to its acronym “PET”, belongs in the category of nuclear medicine. Indeed, the image forming variable in PET is the distribution in the structure under study of a radionuclide administered systemically in the form of a selected radiopharmaceutical ...
openaire   +2 more sources

Positron Emission Tomography

2007
In the 1960s and 1970s, positron emission tomography (PET) was developed as a research tool, particularly for the investigation of neurophysiology.1, 2, 3, 4 In the 1980s and 1990s, the clinical utility of PET in oncology, neurology, and cardiology was demonstrated.5, 6, 7, 8, 9, 10 The approval of reimbursement by the U.S.
Ramsey D. Badawi, Frederic H. Fahey
openaire   +3 more sources

Positron-Emission Tomography

2013
Positron emission tomography (PET) is a radiotracer imaging technique, which permits the in vivo quantitative measurement of biological processes non-invasively. The science and technology behind PET involves radiotracing and tomography. In the process of PET imaging, the compound labeled with a positron-emitting isotope is injected into body.
Chai Pei, Baoci Shan, Zhiming Zhang
openaire   +3 more sources

Positron Emission Tomography/Computed Tomography

Seminars in Nuclear Medicine, 2008
Accurate anatomical localization of functional abnormalities obtained with the use of positron emission tomography (PET) is known to be problematic. Although tracers such as (18)F-fluorodeoxyglucose ((18)F-FDG) visualize certain normal anatomical structures, the spatial resolution is generally inadequate for accurate anatomic localization of pathology.
openaire   +3 more sources

Home - About - Disclaimer - Privacy